Gsa Capital Partners LLP Inovio Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$0.35 - $0.53 $1.22 Million - $1.85 Million	3,499,581 Added 1178.52%	3,796,529 $1.94 Million
Q3 2023 Nov 15, 2023	BUY	$0.38 - $0.58 $112,840 - $172,229	296,948 New	296,948 $115,000
Q1 2023 May 12, 2023	SELL	$0.79 - $1.91 $47,246 - $114,229	-59,806 Reduced 37.36%	100,274 $82,000
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $225,712 - $400,200	160,080 New	160,080 $250,000
Q2 2022 Aug 09, 2022	SELL	$1.44 - $3.98 $83,930 - $231,974	-58,285 Reduced 60.06%	38,755 $67,000
Q1 2022 May 11, 2022	BUY	$2.97 - $5.2 $124,986 - $218,831	42,083 Added 76.57%	97,040 $348,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $105,104 - $157,129	21,063 Added 62.14%	54,957 $274,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $72,946 - $98,721	10,188 Added 42.98%	33,894 $243,000
Q2 2021 Aug 05, 2021	SELL	$6.23 - $10.03 $5,357 - $8,625	-860 Reduced 3.5%	23,706 $220,000
Q1 2021 May 10, 2021	BUY	$8.81 - $16.96 $50,005 - $96,264	5,676 Added 30.05%	24,566 $228,000
Q4 2020 Feb 03, 2021	BUY	$8.5 - $12.85 $160,565 - $242,736	18,890 New	18,890 $167,000
Q2 2020 Aug 11, 2020	SELL	$7.14 - $31.69 $195,993 - $869,890	-27,450 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.98 - $14.09 $81,801 - $386,770	27,450 New	27,450 $204,000
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $476,189 - $770,204	-115,300 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$5.36 - $6.37 $618,008 - $734,461	115,300	115,300 $731,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.02B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.